Complex Regional Pain Syndrome

Clinical guidelines for managing neurogenic inflammatory pain, evaluating Budapest clinical criteria, and reviewing physical therapy and neuromodulation interventions.

⏱️ 4 min read

Table of Contents

🧠 Standard of Care & Symptoms

Complex Regional Pain Syndrome (CRPS), formerly known as Reflex Sympathetic Dystrophy (RSD), is a disabling, chronic pain condition that usually affects a single limb following trauma.

🧬 Diagnostics & Budapest Criteria

Diagnosis is clinical, guided by the internationally accepted Budapest Criteria. Objective tests are used to support the diagnosis and exclude mimics.

Neurogenic Inflammation & NMDA Sensitization

CRPS is driven by ongoing inflammatory and central nervous system changes:

πŸ’Š Physical Therapy & Neuromodulation

A multidisciplinary approach must be initiated early to restore function and prevent irreversible contractures.

πŸ”¬ Active Clinical Trials

Clinical trials are currently evaluating low-dose ketamine infusion protocols, novel bisphosphonate classes, high-frequency spinal cord stimulators, and anti-nerve growth factor (NGF) monoclonal antibodies.

NCT06922455: Intravenous Bisphosphonate Therapy

A Phase III clinical trial evaluating intravenous bisphosphonate therapy for early-stage CRPS Type 1 to prevent bone loss and reduce pain.

Key Inclusion: Age 18 to 70, diagnosed with CRPS Type 1 within 6 months of symptom onset, displaying active vasomotor and sudomotor symptoms, and baseline osteopenia confirmed on DEXA.
NCT07050199: Closed-Loop Dynamic Spinal Cord Stimulation (SCS)

Testing a novel closed-loop spinal cord stimulator that dynamically adjusts output based on spinal cord activation patterns.

Key Inclusion: Age ≥ 18, severe refractory CRPS of a single lower limb (Type 1 or Type 2) ≥ 1 year, failed ≥ 3 classes of pharmacotherapy, and successful trial stimulation showing ≥ 50% pain reduction.
NCT07119088: Outpatient Low-Dose Ketamine Infusions

Comparing a 5-day outpatient low-dose ketamine infusion protocol versus placebo for refractory CRPS pain.

Key Inclusion: Age 18 to 65, diagnosed with moderate-to-severe CRPS ≥ 6 months, mean daily pain score ≥ 5/10, and no history of severe hepatic dysfunction or psychiatric disease.
Important: Browse actively recruiting clinical trials in our Clinical Trials Catalogue to find a local study.

πŸ—ΊοΈ Next Steps After Diagnosis

If you have recently been diagnosed with Complex Regional Pain Syndrome, establish these immediate pathways:

  1. Initiate Physical Therapy Immediately: Do not immobilize the limb. Gentle, active movements are critical to prevent joint contractures and muscle atrophy.
  2. Optimize Neuropathic Medications: Work with a pain management specialist to start gabapentinoids, tricyclic antidepressants, or bisphosphonates within the first 3 months of symptom onset.
  3. Discuss Sympathetic Blocks: If pain prevents physical therapy, schedule a diagnostic sympathetic nerve block to create a therapeutic window.
  4. Incorporate Psychological Support: Chronic severe pain reorganizes brain pathways and causes secondary anxiety and depression; cognitive-behavioral therapy (CBT) is an essential co-therapy.

❓ Patient FAQ

Q: Why does my limb feel freezing cold but look bright red?
A: This is due to profound vasomotor instability. The sympathetic nervous system, which controls blood vessel constriction, is dysfunctional. Vessels may randomly constrict, causing the limb to feel freezing cold, or dilate, causing it to flush bright red. Over time, the limb often transitions from a warm, red state to a cold, cyanotic (blue) state.

Q: Can I just immobilize my arm in a sling to let the pain settle?
A: No. Immobilization is one of the worst things you can do for CRPS. Keeping the limb still accelerates joint stiffness, bone loss (osteopenia), and muscle wasting. It also reinforces the brain's maladaptive belief that the limb is injured, worsening the central pain pathways. Active, progressive rehabilitation is vital.

Get the Free 2026 Clinical AI Directory

Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.

Request Directory via Email